in this issue
Chemical Week Magazine :: Newsbriefs
AMRI shuts Syracuse
6:42 AM MDT | April 25, 2014
Albany Molecular Research Inc. (AMRI; Albany, NY) says that it will transition discovery and development services (DDS) activities at its Syracuse, NY, site to other sites within AMRI and will cease operations at Syracuse by the end of June. This research center provides services, including chemical process R&D, custom chemical synthesis, and scale-up of pharmaceutical intermediates and final products, to the global pharmaceutical industry. As part of the transition, Syracuse DDS capabilities and some employees will transfer to other AMRI...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee